{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-019883","form_type":"8-K","ticker":"ABEO","cik":"0000318306","company_name":"ABEONA THERAPEUTICS INC.","filed_at":"2022-07-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.766181+00:00","generated_at":"2026-06-24T11:41:36.972521+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Abeona regains Nasdaq compliance with minimum bid price requirement","bullets":["Received Nasdaq notification on July 19, 2022 confirming compliance with Listing Rule 5550(a)(2).","Minimum $1.00 closing bid price was maintained for 10 consecutive trading days through July 18, 2022.","Matter is now closed; common stock will continue trading on Nasdaq Capital Market.","Press release issued July 20, 2022 announcing the compliance regain."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-019883","json":"https://secwatch.observer/filing/0001493152-22-019883.json","markdown":"https://secwatch.observer/filing/0001493152-22-019883.md","text":"https://secwatch.observer/filing/0001493152-22-019883.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/318306/000149315222019883/0001493152-22-019883-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/318306/000149315222019883/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T11:41:36.972521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}